Article
Determinants of plasminogen activator inhibitor 1 activity in treated NIDDM and its relation to a polymorphism in the plasminogen activator inhibitor 1 gene.
Diabetes - 1 Jan 1995
Panahloo A, Mohamed-Ali V, Lane A, Green F, Humphries S E, Yudkin J S
Abstract excerpt
Plasminogen activator inhibitor 1 (PAI-1) activity is increased in patients with non-insulin-dependent diabetes mellitus (NIDDM) and may contribute to their excess risk of cardiovascular disease. We examined the determinants of PAI-1 activity in 146 NIDDM subjects by using specific assays of insulin and intact and des-31,32-proinsulin and measures of insulin resistance, relating these measurements to serum...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
